Salter Malcolm 4
4 · C4 Therapeutics, Inc. · Filed Sep 21, 2021
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Sale
Common Stock
2021-09-17$49.89/sh−755$37,667→ 12,917 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.